Apogee Therapeutics, Inc. (APGE) has 10 open-market insider trades by 7 insiders since 2023. The most active filer is Carl Dambkowski.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Evan Harwin | Dir | — | 1 | $133.5M | 2026-01-22 |
| Fairmount Funds Management LLC | Dir | — | 1 | $50.0M | 2026-08-07 |
| Nimish P. Shah | Dir | — | 1 | $29.8M | 2025-10-10 |
| Michael Thomas Henderson | CEO | — | 2 | $3.1M | 2026-07-10 |
| Carl Dambkowski | — | — | 3 | $2.2M | 2026-07-14 |
| Mark C. McKenna | Dir | — | 1 | $991K | 2024-12-12 |
| Jane Henderson | CFO | — | 1 | $290K | 2026-07-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Thomas Henderson | CEO | Sell | $2.7M | 2026-07-08 |
| Carl Dambkowski | — | Sell | $730K | 2026-07-01 |
| Carl Dambkowski | — | Sell | $3.5M | 2026-06-22 |
| Michael Thomas Henderson | CEO | Sell | $10.6M | 2026-06-22 |
| Michael Thomas Henderson | CEO | Sell | $1.7M | 2026-06-10 |
| Carl Dambkowski | — | Sell | $433K | 2026-06-03 |
Companies that share insiders with APGE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Michael Thomas Henderson | CEO | Sell | $1.6M | 2026-05-13 |
| Carl Dambkowski | — | Sell | $463K | 2026-05-06 |
| Jane Henderson | CFO | Sell | $164K | 2026-05-01 |
| Jane Henderson | CFO | Sell | $180K | 2026-04-16 |
| Michael Thomas Henderson | CEO | Sell | $1.7M | 2026-04-08 |
| Jane Henderson | CFO | Sell | $170K | 2026-04-01 |
| Carl Dambkowski | — | Sell | $467K | 2026-04-01 |
| Jane Henderson | CFO | Sell | $170K | 2026-03-25 |
| Michael Thomas Henderson | CEO | Sell | $1.5M | 2026-03-11 |